Cadrenal Therapeutics, Inc. Shares Outstanding (Cover Page)
Cadrenal Therapeutics, Inc. (CVKD) had Shares Outstanding (Cover Page) of 3.57 million shares as of 2026-08-13, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-13: Entity Common Stock, Shares Outstanding 3.57M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 2.87M shares.
- 2026-03-27: Entity Common Stock, Shares Outstanding 2.51M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 2.08M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-13 | 3.57M shares 10-Q · filed 2026-08-13 |
| 2026-05-06 | 2.87M shares 10-Q · filed 2026-05-07 |
| 2026-03-27 | 2.51M shares 10-K · filed 2026-03-31 |
| 2025-11-10 | 2.08M shares 10-Q · filed 2025-11-10 |
| 2025-08-11 | 2.05M shares 10-Q · filed 2025-08-11 |
| 2025-05-08 | 1.97M shares 10-Q · filed 2025-05-08 |
| 2025-03-13 | 1.88M shares 10-K · filed 2025-03-13 |
| 2024-11-07 | 1.66M shares 10-Q · filed 2024-11-07 |
| 2024-08-07 | 16.01M shares 10-Q · filed 2024-08-07 |
| 2024-05-09 | 16.01M shares 10-Q · filed 2024-05-09 |
| 2024-03-08 | 16.01M shares 10-K · filed 2024-03-11 |
| 2023-11-09 | 13.02M shares 10-Q · filed 2023-11-09 |
| 2023-08-09 | 13.02M shares 10-Q · filed 2023-08-10 |
| 2023-05-09 | 11.72M shares 10-Q · filed 2023-05-10 |
| 2023-03-29 | 11.63M shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |